GlobeNewswire

Align Technology Launches New iTero Element 5D Imaging System for Comprehensive Preventative and Restorative Oral Care at IDS

Del

SAN JOSE, Calif., Feb. 18, 2019 (GLOBE NEWSWIRE) --

  • First intraoral scanner with near-infrared imaging (NIRI) technology that scans the internal structure of a tooth (enamel & dentin) in real time1.
  • First integrated dental imaging system that simultaneously records 3D, intra-oral color and NIRI, and enables comparison over time using iTero® TimeLapse1.
  • NIRI technology of the iTero Element® 5D system aids in detection and monitoring of interproximal caries lesions above the gingiva without using harmful radiation1.
  • New web-based interface MyiTero.com complements visualization of the iTero Element 5D system.
  • Limited-release direct doctor-lab workflow automatically sends scan to lab of choice.

Align Technology, Inc. (NASDAQ: ALGN) today announced that it is launching the iTero Element 5D Imaging System, which provides a new comprehensive approach to clinical applications, workflows and user experience that expands the suite of existing high-precision, full-color imaging and fast scan times of the iTero Element portfolio. The entire iTero product family, including the iTero Element 5D Imaging System, will be showcased at the 38th International Dental Show (IDS) in Cologne Germany, which runs March 12 – 16, 2019.

iTero Element 5D Imaging System: more than just a scanner
In addition to offering all of the features and functionality that doctors have come to expect and rely on with the iTero Element 2 scanner, the iTero Element 5D scanner is the first integrated dental imaging system that simultaneously records 3D, intra-oral color and NIRI images and enables comparison over time using iTero TimeLapse1. Integrated 3D,  intra-oral color and NIRI technology of the iTero Element 5D Imaging System aids in detection and monitoring of interproximal caries lesions above the gingiva without using harmful radiation1. With one full arch scan, in as little as 60 seconds, the iTero Element 5D Imaging System provides doctors with powerful visualization capabilities, including the following:

  • 3D impressions for restorative and orthodontic work
  • Analysis instruments, such as the occlusal clearance tool2
  • NIRI imagery
  • Intraoral camera imagery
  • iTero TimeLapse technology
  • Invisalign® Outcome Simulator2
  • Invisalign Progress Assessment2

“The iTero Element 5D Imaging System combines the cutting-edge technology of the iTero Element portfolio of intraoral scanners, with advanced integrated imaging features, such as NIRI, which aids in interproximal caries detection and clear intra-oral images with the built-in intraoral camera,” said Zelko Relic, Align Technology, CTO and senior vice president, global research and development. “With this new imaging system, doctors can efficiently and effectively scan every patient at every visit and visualize treatment options together that result in more informed decisions for optimum oral care.”  

“Diagnosing carious lesions or ‘cavities,’ especially ones that are interproximal or between teeth, can be hampered by numerous factors, including variations in tooth shape and alignment, traditional X-ray film limitations that include variability in exposure levels, poor angulations in image capture or overlapping contacts in the image, and more,” said Dr. Mitra Derakhshan, Align Technology, vice president, global clinical. “The iTero Element 5D Imaging System aids doctors in detecting and monitoring the progression of interproximal cavities above the gingiva without harmful radiation, thereby helping to ensure that their patients receive even better care.”

Dr. Tim Nolting, a general practioner from Freudenberg, Germany, who was part of the iTero Element 5D Imaging System limited market release said, “The iTero Element 5D scanner has been a real game changer and given me a totally new reason to incorporate digital technology in my practice. Patients value minimally invasive treatment and radiation free diagnosis. With the addition of the iTero Element 5D System in my diagnostic tool box, diagnosis itself is easier to make and since I can show my patients what I am seeing, they understand the situation better and in turn accept the proposed treatment.”

“The pace of innovation at Align continues to accelerate, and the Element 5D Imaging System expands the iTero portfolio by offering dental professionals a wide range of powerful scanning technology at every price point,” said Yuval Shaked, Align Technology, senior vice president and managing director, iTero Scanners and Services.  “As the leader in digital scanning technology with over 20 years of experience, we understand the nature of platform evolution and how important it is to support our doctors and provide an upgrade path that protects their investment. With iTero Element 5D Imaging System, dental professionals now have the ability to invest in more than an intraoral scanner, thus maximizing opportunities within their dental practice. The platform nature of iTero Element 5D System makes it easy for dental professionals to upgrade to the latest digital technology when they are ready.”

MyiTero.com: New web-based interface that frees the scanner for scanning
Align Technology now also offers a web-based platform called MyiTero.com that complements the comprehensive visualization of the iTero Element 5D Imaging System and can be used to set up prescription before the appointment and review scans with the patient on multiple devices, giving the practice the flexibility to assist more patients with this cutting-edge technology. MyiTero.com frees up the scanner so the practice can really maximize the utilization of their scanner and the overall investment in the technology.

Direct doctor-lab workflow in limited release: Workflow options that fit doctor-lab needs
Align Technology is continuing to streamline workflows for dentists and labs with the addition of direct doctor-lab workflow. The new workflow will allow the scan to be automatically sent to the doctor’s lab of choice and the doctor can engage with the lab through the MyiTero.com account to determine if the scan is acceptable or if additional information is needed. This workflow will continue to be supported with on-demand services like iTero modeling and iTero customer milled models, both unique to iTero Element scanners, that the labs have come to count on. Direct doctor-lab workflow is currently in limited market testing in North America and Europe.

1 Data on file at Align Technology, as of December 4, 2018.
2 Comes standard in all iTero Element scanners.

The iTero Element 5D Imaging System is commercially available now in Canada, European Union countries accepting CE-Marking (excluding Greece), Switzerland, Norway, Australia, New Zealand, Hong Kong and Thailand. The iTero Element 5D Imaging System is not yet available in the United States or Latin America.

Information about the iTero Element 5D Imaging System can be found at http://www.itero.com/en.

Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, and iTero® intraoral scanners and services. Align's products help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com.

Align Technology                                                                                        
Karina Ludz                                                                                           
(316) 21143420                                                                                      
kludz@aligntech.com                                                                           

Zeno Group
Sarah Johnson
(828) 551-4201
sarah.johnson@zenogroup.com

Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/b06170ee-c19b-4093-b5c1-fcbc8aae9455

http://www.globenewswire.com/NewsRoom/AttachmentNg/76a84de2-12fd-4978-8699-7a7a07d5a706

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Tenaris to Acquire IPSCO Tubulars from TMK22.3.2019 13:58:00 CETPressemelding

LUXEMBOURG, March 22, 2019 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE, Buenos Aires and Mexico: TS and MTA Italy: TEN) announced today that it has entered into a definitive agreement to acquire from PAO TMK, a Russian company and manufacturer of steel pipe, 100% of the shares of its wholly owned U.S. subsidiary IPSCO Tubulars, Inc., for US$1,209 million, on a cash-free, debt-free basis, which includes US$270 million of working capital. The transaction is subject to regulatory approvals, including approval by the U.S. antitrust authorities, and other customary conditions. IPSCO Tubulars is a U.S. domestic producer of seamless and welded OCTG and line pipe products, with an annual production capacity of 450,000 metric tons of steel bars, 400,000 metric tons of seamless pipe and 1,000,000 metric tons of welded pipe, and production facilities spread throughout the country. The acquisition would enhance Tenaris’s position and local manufacturing presence in the U.S. market, extending its produc

Oxford Immunotec Announces Chief Financial Officer Transition21.3.2019 21:01:00 CETPressemelding

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that Richard Altieri, the Company’s Chief Financial Officer (CFO), will retire on April 30, 2019. The Company has appointed Matthew McLaughlin, currently Chief Financial Officer, GE Healthcare – U.S. and Canada, as his successor. Mr. McLaughlin will join Oxford Immunotec as CFO on April 8, 2019. Today’s announcement concludes an extensive search process conducted by the Company. As part of the planned succession, Mr. Altieri, who has led Oxford Immunotec’s global finance organization as CFO since 2012, will remain an active member of the Company’s management team until his retirement date. “During his seven year tenure, Rick successfully managed multiple financing rounds, including the Company's IPO, the acquisition and financial integration of three companies and, most recently, the dives

Blackhawks, Flyers, Sabres and Lightning Headline the 2019 NHL Global Series21.3.2019 15:34:00 CETPressemelding

Chicago Blackhawks and Philadelphia Flyers to Open Regular Season in Prague, Czech Republic on Oct. 4 Buffalo Sabres and Tampa Bay Lightning to Face Off in a Pair of Games in Stockholm, Sweden on Nov. 8 and Nov. 9 2019 NHL Global Series Challenge to feature Blackhawks vs. Eisbären Berlin on Sept. 29 in Berlin, Germany and Flyers vs. Lausanne HC on Sept. 30 in Lausanne, Switzerland Tickets to Games in Berlin, Prague and Stockholm Available for Purchase on Wednesday, March 27; Tickets to Game in Lausanne Available for Purchase on Wednesday, April 10 NEW YORK/TORONTO, March 21, 2019 (GLOBE NEWSWIRE) -- The National Hockey League (NHL) and the National Hockey League Players’ Association (NHLPA), in conjunction with Live Nation Sweden, today announced that the Buffalo Sabres, Chicago Blackhawks, Philadelphia Flyers and Tampa Bay Lightning will participate in the 2019 NHL Global Series. The Chicago Blackhawks and Philadelphia Flyers will play their 2019-20 season-opening game against each ot

Farmako: World's Largest Import Contract for Pharmaceutical Cannabis21.3.2019 15:10:00 CETPressemelding

German Farmako secures 50 tonnes of flowers and oils from Polish company Pharmacann Polska FRANKFURT, March 21, 2019 (GLOBE NEWSWIRE) -- Farmako will import 50 tonnes of pharmaceutical cannabis from Pharmacann Polska into the European market over the next four years. This provides the basis for a reliable supply of pharmaceutical cannabis for millions of patients in the European healthcare system. The company expects a total revenue of several hundred million Euros from the agreed exclusive partnership. Founded in September 2018, Farmako now has grown to 40 employees and is distributing high-quality pharmaceutical cannabis to German pharmacies since March 2019. This is the biggest Cannabis contract to date, and the first big contract without participation of a Canadian LP. Farmako has signed an exclusive and binding agreement to import and distribute 50 tons of pharmaceutical cannabis over four years. Farmako and Pharmacann Polska enter strategic partnership to develop custom tailored

NexOptic Appoints Rich Geruson, Former Lexmark CEO, to Board of Directors21.3.2019 14:00:00 CETPressemelding

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- NexOptic Technology Corp. ("NexOptic" or the "Company") (TSX VENTURE: NXO) (OTCQX: NXOPF) (FRANKFURT: E3O1) is pleased to announce that Richard J. (Rich) Geruson has joined its Board of Directors, effective immediately. Mr. Geruson’s experience spans CEO roles at Lexmark International, Phoenix Technologies and VoiceSignal Technologies, and Senior Vice President and executive positions at Nokia, IBM, Toshiba, and McKinsey & Co. As CEO of Lexmark International, a multibillion-dollar imaging technology and solutions company with 10,000 employees, he grew printer sales faster than at any time in the preceding 10 years while simultaneously executing extensive process reengineering, transforming the business from negative EBITDA and high debt to positive multi-hundred-million-dollar EBITDA and a healthy debt profile. While CEO of Phoenix Technologies, he achieved consistently high profit year-over-year for six years straight in